vTv Therapeutics (VTVT) Says it will Pre-specify New Subgroup with FDA and Report Phase 3 Part B Results in June
Tweet Send to a Friend
vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that based on post-hoc analyses of the data from Part A of the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
